how many people use glp-1 The Access Gap: Mapping Who Can Actually Afford America's Miracle Weight-Loss Drugs US households with GLP-1 users

Book Today.

The Global GLP-1 Receptor Agonists Obesity Drugs Market was valued at USD 9.96 Billion in 2024 and is expected to reach USD 33.12 Billion by 2032, growing at a CAGR of 16.20% (2025-2032).

SGLT2 inhibitors cause a carbohydrate deficit by glucosuria, which leads to an increased glucagon/insulin ratio, the metabolic shift from glucose to lipid utilization causing ketogenesis, and hence euglycemic DKA

What strategies have you found helpful in maintaining muscle mass

Now it might protect your brain

Yesterday, the FDA published a reminder clarifying the status of compounded Tirzepatide now that the shortage for this GLP-1 product has been resolved.